Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pascual-Serra, Raquel
25  Ergebnisse:
OpenAccess-Volltexte X
englisch X
Personensuche X
?
1

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Imp..:

Arconada-Luque, Elena ; Jiménez-Suarez, Jaime ; Pascual-Serra, Raquel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316148/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Imp..:

Arconada Luque, Elena ; Jiménez-Suarez, Jaime ; Pascual-Serra, Raquel...
Cancers;14(14).  , 2022
Link: https://hdl.handle.net/1..
 
?
3

ERK5 Is a Major Determinant of Chemical Sarcomagenesis : Im..:

Arconada-Luque, Elena ; Jiménez-Suarez, Jaime ; Pascual-Serra, Raquel...
Agencia Estatal de Investigación RTI2018-094093-B-I00.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
4

Blockage of autophagic ux is associated with lymphocytosis ..:

Roche, Olga ; Romero-Macías, Juan-Ramón ; Pascual-Serra, Raquel...
Publisher's version.  , 2019
Link: http://hdl.handle.net/10..
 
?
5

P53 pathway is a major determinant in the radiosensitizing ..:

Fernández-Aroca, Diego M ; Roche, Olga ; Sabater, Sebastiá...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2019
Link: http://hdl.handle.net/10..
 
?
6

Erk5 pathway is a new indirect target of sorafenib:

Ortega-Muelas, Marta ; Muñoz-Martinez-Blanco, L ; Pascual-Serra, Raquel...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2018
Link: http://hdl.handle.net/10..
 
?
7

Autophagic cell death associated to Sorafenib in renal cell..:

Serrano-Oviedo, Leticia ; Ortega-Muelas, Marta ; García-Cano, Jesús...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2018
Link: http://hdl.handle.net/10..
 
?
8

Palbociclib radiosensitizes colon and lung cancer cell line..:

Fernández-Aroca, Diego M ; Roche, Olga ; Ortega-Muelas, Marta...
Publisher's version.  , 2018
Link: http://hdl.handle.net/10..
 
?
9

Exploiting the potential of autophagy in cisplatin therapy:..:

García-Cano, Jesús ; Ambroise, Gorbatchev ; Pascual-Serra, Raquel...
Oncotarget.  , 2016
Link: http://hdl.handle.net/10..
 
?
10

p38MAPK and Chemotherapy: We Always Need to Hear Both Sides..:

García-Cano, Jesús ; Roche, Olga ; Cimas, Francisco J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928511/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
11

p38MAPK and Chemotherapy: We always need to hear both Sides..:

García-Cano, Jesús ; Roche, Olga ; Cimas, Francisco J...
Reproducció del document publicat a: https://doi.org/10.3389/fcell.2016.00069.  , 2016
Link: http://hdl.handle.net/24..
 
?
12

Exploiting the potential of autophagy in cisplatin therapy:..:

García-Cano, Jesús ; Ambroise, Gorbatchev ; Pascual-Serra, Raquel...
Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.3902.  , 2015
Link: http://hdl.handle.net/24..
 
?
13

MKP1 mediates chemosensitizer effects of E1a in response to..:

Cimas, Francisco J ; Callejas-Valera, Juan Luis ; Pascual-Serra, Raquel...
Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.6574.  , 2015
Link: http://hdl.handle.net/24..
 
?
14

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Imp..:

Elena Arconada-Luque ; Jaime Jiménez-Suarez ; Raquel Pascual-Serra...
Cancer Biomarkers.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Imp..:

Elena Arconada-Luque ; Jaime Jiménez-Suarez ; Raquel Pascual-Serra...
https://www.mdpi.com/2072-6694/14/14/3509.  , 2022
Link: https://doi.org/10.3390/..
 
1-15